Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,900
Employees9,900
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,900
Employees9,900

ELAN Key Statistics

Market cap
10.86B
Market cap10.86B
Price-Earnings ratio
-43.82
Price-Earnings ratio-43.82
Dividend yield
Dividend yield
Average volume
7.47M
Average volume7.47M
High today
$21.95
High today$21.95
Low today
$21.40
Low today$21.40
Open price
$21.46
Open price$21.46
Volume
381.58K
Volume381.58K
52 Week high
$27.72
52 Week high$27.72
52 Week low
$12.40
52 Week low$12.40

Stock Snapshot

The current Elanco(ELAN) stock price is $21.74, with a market capitalization of 10.86B. The stock trades at a price-to-earnings (P/E) ratio of -43.82.

On 2026-05-13, Elanco(ELAN) stock moved within a range of $21.40 to $21.95. With shares now at $21.74, the stock is trading +1.6% above its intraday low and -1.0% below the session's peak.

Trading volume for Elanco(ELAN) stock has reached 381.58K, versus its average volume of 7.47M.

The stock's 52-week range extends from a low of $12.40 to a high of $27.72.

The stock's 52-week range extends from a low of $12.40 to a high of $27.72.

ELAN News

Simply Wall St 3d
Why Elanco Is Up 7.3% After Raising 2026 Revenue Guidance On New Product Momentum

In the first quarter of 2026, Elanco Animal Health reported revenue of US$1,371 million versus US$1,193 million a year earlier, while net income eased to US$57...

Why Elanco Is Up 7.3% After Raising 2026 Revenue Guidance On New Product Momentum
TipRanks 6d
Elanco price target raised to $30 from $28 at JPMorgan

JPMorgan analyst Chris Schott raised the firm’s price target on Elanco (ELAN) to $30 from $28 and keeps an Overweight rating on the shares. Unlock hedge fund-l...

TipRanks 6d
Elanco raises FY26 adjusted EPS view to $1.03-$1.09 from $1.00-$1.06

Consensus $1.03. Raises FY26 revenue view $5.01B-$5.09B from $4.95B-$5.02B, consensus $5B. Raises FY26 adjusted EBITDA view to $975M-$1.01B from $955M-$985M. “O...

Analyst ratings

94%

of 17 ratings
Buy
94.1%
Hold
5.9%
Sell
0%

More ELAN News

TipRanks 7d
Elanco Earnings Call Highlights Innovation-Led Growth

Elanco Animal Health ((ELAN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data an...

Benzinga 7d
Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum

The animal health company also released better-than-expected first-quarter earnings. Elanco Stock Rises On Emergency Use Authorization Approvals The recent appr...

Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum
Nasdaq 7d
Elanco Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Elanco Q1 2026 Earnings Transcript

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.